AMINAmerican International Industries, Inc.
The schedule
- Thu15Oct
Critical window for announcing a letter of intent for a reverse merger.
- Fri13Nov
Q3 2026 financial disclosure evaluating M&A progress and operational costs.
- Mon15Feb
Potential finalization of a definitive merger agreement and shareholder proxy.
- Wed31Mar
Full-year 2026 financial disclosure and 10-K filing.
Past
- Mon10Aug
Actual outcome: Bull · $0.10 at outcome
AMIN experienced a massive move due to the announcement of a key regulatory approval, likely for a critical product or therapy. This approval significantly enhanced the company's market position and valuation, leading to a substantial price increase. The event marked a pivotal milestone in the company's development pipeline. [Market retrospective · Long-Term (31–75 days)] Updated observation 2026-09-10: +13150.0% from 2026-04-28 (~25.9σ). Target evaluation date 2026-09-25 (not yet reached as of 2026-09-10).
AMIN experienced a massive move due to the announcement of a key regulatory approval, likely for a critical product or therapy. This approval significantly enhanced the company's market position and valuation, leading to a substantial price increase. The event marked a pivotal milestone in the company's development pipeline. [Market retrospective · Long-Term (31–75 days)] Updated observation 2026-09-10: +13150.0% from 2026-04-28 (~25.9σ). Target evaluation date 2026-09-25 (not yet reached as of 2026-09-10).
